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16 December 2016 
Dear Editor, 
 
In reply to: “Meyer CP, et al. The association of hypoalbuminemia with early perioperative 
outcomes – A comprehensive assessment across 16 major procedures” 
 
We read with interest the recent work by Meyer and colleagues (1).  In this study, utilising data 
from the ACS-NSQIP database, the presence of pre-operative hypoalbuminemia was associated 
with adverse outcomes across a number of major surgeries.  Taking those undergoing colectomy 
as an example, controlling for covariates such as gender, race, comorbidity indices and BMI, a 
serum albumin<3.5g/dl was associated with increased risk of post-operative complications 
(adjusted odds ratio (OR) 1.41), blood transfusion (OR 1.32), prolonged length of stay (OR 1.71) 
and mortality (OR 2.29) (all P<0.001).  Similar results were observed across a number of other 
oncological, cardiovascular and orthopedic procedures.  These results largely mirror those of 
Gibbs and colleagues who, utilising the National VA Surgical Risk Study database, found that a 
decrease in serum albumin from 4.6g/dl to 2.1g/dl was associated with an exponential increase in 
30-day mortality from <1% to 28% (2).  Risk of post-operative morbidity similarly increased. 
 
Although proposed as a marker of nutrition, hypoalbuminemia in the present study is unlikely to 
reflect poor nutritional status.  Serum albumin correlates poorly with clinical assessment of 
nutritional status (3), and in states of malnutrition, serum albumin concentrations are often 
maintained at the expense of other sources of protein such as skeletal muscle (4).  In  
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such circumstances, hypoalbuminemia is a late, often pre-terminal occurrence.  Therefore, given 
that only 5% of patients with hypoalbuminemia in the present study had a BMI<18.5, it is 
unlikely that this is the primary mechanism responsible for the present associations with adverse 
outcome. 
 
Albumin has long been recognised to be a negative acute phase reactant, circulating 
concentrations reflecting, in part, the magnitude of the systemic inflammatory response (5).  
More recently, it has become apparent that markers of the systemic inflammatory response such 
as C-reactive protein and neutrophil count have a strong independent association with cancer 
specific (6) (7) and overall (8)mortality. 
 
Although alluded to by the authors in their discussion, it is important to note that the results of 
their surgical mortality study (1), and that of Gibbs and colleagues (2), fail to control for the 
important confounding effect of the systemic inflammatory response.  Moreover, whether 
hypoalbumaemia is mainly the result of a nutritional deficit or secondary to a systemic 
inflammatory response is of considerable importance since the former would suggest that 
nutritional intervention may be beneficial.  In contrast, if the latter was dominant then it would 
suggest an anti-inflammatory intervention may be beneficial. 
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Irrespective, it is clear that if albumin is being monitored then a marker of the systemic 
inflammatory response such as C-reactive protein should also be monitored.  Indeed, work by our 
group over the past decade or so has identified the prognostic value of the combination of C-
reactive protein and albumin in patients with cancer and with chronic disease (8-10). This 
systemic inflammation based prognostic score (termed the modified Glasgow Prognostic Score, 
mGPS, Table 1), has been shown to have consistent prognostic value in a variety of clinical 
scenarios.  We recommend such an approach in the analysis carried by Meyer and colleagues. 
 
 
Yours sincerely, 
 
Mr James Park, Clinical Lecturer in Colorectal Surgery 
Professor Paul Horgan, Professor of Surgery 
Professor Donald McMillan, Professor of Surgical Sciences 
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Table 1 – The modified Glasgow Prognostic Score 
Score Determinant 
mGPS 0 CRP ≤10/mg/L 
mGPS 1 CRP >10/mg/L 
mGPS 2 CRP >10/mg/L and Albumin <35g/L 
 
